Viewing Study NCT01866904



Ignite Creation Date: 2024-05-06 @ 1:40 AM
Last Modification Date: 2024-10-26 @ 11:07 AM
Study NCT ID: NCT01866904
Status: TERMINATED
Last Update Posted: 2018-09-04
First Post: 2013-05-29

Brief Title: Long-Term rIsk Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
Sponsor: AstraZeneca
Organization: AstraZeneca

Study Overview

Official Title: TIGRIS Long-Term rIsk Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: TERMINATED
Status Verified Date: 2018-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Study was terminated in order to secure the data quality of the study in terms of follow-up rates and data completeness
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TIGRIS
Brief Summary: THis study is intended to provide contemporary data on the burden of disease in patients 1 to 3 years post-MI including a description of patient characteristics current treatment patterns rate of major CV events and healthcare resource utilization in a real world patient population at high atherothrombotic risk
Detailed Description: TIGRIS is a multinational multi-centre observational prospective longitudinal cohort study which will include stable CAD patients with history of MI 1-3 years ago and high risk of developing atherothrombotic events in a real world setting The follow-up period is 3 years

Patients will undergo clinical assessments and receive standard medical care as determined by the treating physician Patients will not receive experimental intervention or experimental treatment as a consequence of their participation in the study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None